• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

7 diabetes treatment innovations to look out for on World Diabetes Day

November 15, 2021 By Sean Whooley

Insulet Omnipod 5

Insulet OmniPod 5
The Insulet Omnipod 5 [Photo courtesy of Insulet]
The latest installment of Insulet’s (NSDQ:PODD) wearable, automated insulin delivery patch system, Omnipod 5, remains on track for FDA clearance and a subsequent launch later this year, President & CEO Shacey Petrovic said while announcing the company’s third-quarter earnings results.

Omnipod 5 will deliver a number of firsts to the market, building upon the Omnipod DASH, which was cleared in 2019. It will include pairing to Dexcom’s G6 CGM, making Omnipod 5 the first tubeless, wearable, automated insulin delivery system, Petrovic said in an interview earlier this year.

Patients will be able to use a dedicated handheld controller or control the system with a secure app on their smartphone, marking another first.

“We’ve seen in previous generations of other systems where complexity can really prevent people from getting good outcomes and having a good experience,” Petrovic said. “We worked very hard to take as much of the complexity out of the system and make it as easy for people to use as possible.”

Next>>

Pages: Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8

Filed Under: Auto-injectors, Business/Financial News, Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Patient Monitoring, Pharmaceuticals Tagged With: Dexcom, Diabeloop, Eli Lilly, Eli Lilly & Co., Fractyl Health, Insulet, Medtronic, Senseonics, Twin Health

IN CASE YOU MISSED IT

  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM
  • Lifecare takes next steps in CGM implant development
  • Ypsomed brings autoinjector for dual GCG/GLP-1 delivery to China
  • Convatec wins FDA approval for Parkinson’s treatment infusion tech

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS